Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events press coverage 2017 05 15.

Page not found

You are here

Sarah Hawley's perspective piece, "Half of women with early-stage breast cancer consider prophylactic double mastectomy" was recently published in Healio ITJ (in the journals).

Full article can be found here.

Working Group Meeting- Kerry Ryan/Michele Gornick/Darin Zahuranec

Tue, September 26, 2017, 4:00pm
Location: 
NCRC bldg 16 266C

Kerry, Michele, & Darin, will be seeking feedback on wording and flow/ordering of an interview guide. The interview will be with individuals at risk for Huntington’s Disease, individuals with HD, and/or family members/caregivers.

Thu, September 28, 2017

Matthew Corriere designed an decision aid app to patients with Peripheral Artery Disease (PAD) choose their care plan. His work was recently highlighted in MHealth Lab.

Thu, November 09, 2017

Kayte Spector-Bagdady was recently quoted for The State Journal-Register article on the investigation of Southern Illinois University researcher, William Halford's genital herpes vaccine research.

Research Topics: 

CBSSM Seminar: Christina Hunter Chapman, M.D., M.S.

Wed, December 13, 2017, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Christina Hunter Chapman, M.D., M.S.
Assistant Professor of Radiation Oncology

Title: African Americans and Tailored Cancer Screening: Evidence and Ethics

Abstract: Dr. Chapman will discuss the elevated cancer mortality that African Americans experience and the ethical barriers to consideration of tailored cancer screening strategies that have the potential to reduce this disparity.

Fri, December 29, 2017

Kayte Spector-Bagdady was recently quoted in the Undark Magazine article, "The Present and Future Asymmetry of Consumer Genetic Testing" about the difficulties with achieving truly informed consent.

Fri, February 02, 2018

Check out Dr. Kathy Miller's Medscape Oncology Insights interview with Reshma Jagsi from the 2017 annual meeting of the American Society of Clinical Oncology (ASCO) about why physicians often overtreat elderly breast cancer patients.

Brian Zikmund-Fisher presented the Berguer Lecture on Ethics, "Communicating Everything Important Poorly vs. One Critical Thing Well" in Danto Auditorium, Frankel Cardiovascular Center on Friday, January 26th 4 - 5 pm.
 

The Genetics in Primary Care Institute recently launched its new website, featuring co-chairperson Beth Tarini, M.D., assistant professor of pediatrics at the University of Michigan’s C.S. Mott Children’s Hospital.

Along with Robert Saul, M.D., Tarini co-chairs the Institute, which aims to take genetic advances made during the last decade and help make them useful in the practice of primary care pediatrics.

The new website, www.geneticsinprimarycare.org, features information for primary care providers related to genetics testing, ethical, legal and social issues, patient communication and family history.

Tarini’s research focuses on the communication process and the health outcomes associated with genetic testing in pediatrics. She is particularly interested in pediatric population-based screening programs, such as newborn screening. Through her research, Tarini seeks to optimize communication about genetic testing between parents and providers in an effort to maximize health and minimize harm.

The UMHS press release can be found here. Dr. Tarini's featured page can be found here

Thu, July 25, 2013

Dr. Arul Chinnaiyan and his team have been awarded 1 of 4 research grants ($7.97 million pending) from the National Institutes of Health to explore the use of genome sequencing in medical care. The new grants are funded as part of the National Human Genome Research Institute's (NHGRI) Clinical Sequencing Exploratory Research (CSER) program. NHGRI is part of NIH.

The team will sequence the genomes of tumors from 500 patients with advanced sarcoma or other rare cancers to discover new information about genomic alterations, with the goal of eventually customizing therapies. Few clinical trials have been conducted in most rare cancers, and scientists would like to know more about the genetic underpinnings of these diseases. Investigators also plan to evaluate the patient consent process, and the delivery and use of genome sequencing results.

Several CBSSM-affiliated faculty are involved with this project, including Scott Kim, Scott Roberts, Raymond De Vries, Brian Zikmund-Fisher, as well as Post-Doctoral Research Fellow, Michele Gornick.

Pages